🔥Telegram İfşa

📣 Urologists & residents, take your shot at the #EAUGuidelinesCup! 🏆 Test your knowledge in 2 online rounds & win a free pass to #EAU24 in Paris! 🌍 🇫🇷 Hurry, deadline for entries is Jan 31. Don’t miss out! ⏳ #urology #competition European Association of Urology (EAU) EAU Young Urologists European School of Urology (EAU ESU) EAU Young Academics

📋 Our young colleagues from GeSRU are evaluating the use of learning platforms in Urology across Switzerland, Germany and Austria. It is directed towards residents and consultants. Please, take 5 minutes to answer the survey! unipark.de/uc/OnlineWeite…

🚨 Urology residents! Share your "nightmare" cases at #EAU25 in Madrid! 🌟 Submit by Sept 10, 2024. Present & discuss with experts! 👩‍⚕️👨‍⚕️📅 📧 [email protected] 📲 Scan the code in the image! 🗓️ March 21-24, 2025 📍 Madrid, Spain #ESRU European Association of Urology (EAU) European School of Urology (EAU ESU) EAU Young Academics

🎉Excited to announce our upcoming book for aspiring urologists & first-year residents! Covering progress notes, night shifts, DJ placements & more. Peer-reviewed by amazing urologists! Get early access on the Knowuro Reader App or subscribe for updates! knowuro.com/books/unboxed/

📣 Register now! 🏆 Think you know the EAU Guidelines? Prove it at the ESRU & YUO Guidelines Cup! 🔹 Who: EAU Members only 🔹 Why: Showcase expertise, & win free entry to EAU Congress 2025 in Madrid! 📥 Check your email for the registration link. #YUO #ESRU #Urology #EAU

📢 OPPORTUNITY 🚀 Pitch your research ideas in 100 words! 🫵 Submit your QIP, audit, or innovation idea for a chance to 🌟 present live, 🏆 win a NATIONAL prize & ✅ gain expert support. 🔗 Submit here: forms.gle/BTA3oYuLo2J3pX… 🗓️ Deadline: 20/12/24 #BURST10 #BAUS25 #UroSoMe

Opportunity for our 🇨🇭 residents! Check it out!

🚨 WASHOUT study update! 💥 Due to popular demand, we are extending the study duration by 6 months. 📢 300+ sites, 3,000+ patients so far. Don't miss your chance to improve our management of unscheduled haematuria. Sign up now!

IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembrolizumab new SOC for patients with metastatic #UC. Trial #EV302 displaced 30y Platinum-based combos ⏩ PFS benefit: 12.5 vs 6.3 mo (HR= 0.45) ⏩ OS benefit:

We published the first report on the current status of Urology training in Switzerland. Here you find anything you need to know! Should the current training system be changed? Congrats Fabian Aschwanden Luca Afferi Andres Affentranger Silvan Sigg

The BARCODE1 study assessed the use of a polygenic risk score to screen for prostate cancer. Of the 468 persons in at least the 90th percentile of genetic risk who underwent MRI and prostate biopsy, 187 (40.0%) had prostate cancer. Full study: nej.md/44jT8Fn Editorial: